Oviva Diabetes Support: Evaluating clinical outcomes for people with type 2 diabetes following completion of a remote programme of structured education and behaviour change

“Oviva糖尿病支持是一个以患者为中心的数字化项目，为2型糖尿病患者提供结构化教育和行为改变。该计划由营养师一对一提供，在10-12周内提供个性化护理，以支持完成规定的课程，并帮助参与者学会管理自己的病情。它是高度可访问的，因为它是完全远程的（通过电话和Oviva智能手机应用程序交付），课程是通过基于网络的Oviva学习平台交付的，包括引人入胜的多格式内容，如视频，播客和食谱。除了个人营养师的指导外，参与者还可以使用Oviva应用程序自我监测食物摄入量、活动水平和体重。基于结构化教育提供的有效和可获得方法的证据，Oviva糖尿病支持旨在使参与者掌握自我管理技能，并通过有指导的行为改变和自主学习帮助他们养成长期的健康习惯。Oviva糖尿病支持已在13个地区向国民保健服务的参与者提供，与全国平均水平7.6%相比，其使用率达到了90%，这表明用户比传统模式更容易获得创新的服务模式。实际数据还表明，与传统模式相比，参与者的健康和临床结果得到了更好的改善，而且成本更低。该项目将使300名参与者获得Oviva糖尿病支持。伦敦国王学院将对该项目完成后对临床结果的影响进行独立评估，该评估将用于进一步分析NHS节省成本的潜力。此外，评估结果将用于未来更大规模的临床试验，以寻求提供临床有效性的进一步证据。”

"Oviva Diabetes Support is a patient-centred, digitally enabled programme of structured education and behaviour change for people with type 2 diabetes. Delivered 1-to-1 by dietitians, the programme provides individualised care over 10-12 weeks to support completion of a defined curriculum and help the participant learn to manage their condition.It is highly accessible as it is fully remote (delivered via phone calls and the Oviva smartphone app) and the curriculum is delivered via a web-based Oviva Learning Platform, comprised of engaging, multi-format content, such as videos, podcasts and recipes. Participants can also use the Oviva app for self-monitoring of food intake, activity levels and weight, in addition to coaching from their personal dietitian.Building on evidence of effective and accessible approaches to structured education provision, Oviva Diabetes Support aims to equip participants with self-management skills and help them adopt long-term healthier habits through guided behaviour change and self-directed learning.Oviva Diabetes Support has been made available to participants in the NHS in 13 areas and has demonstrated uptake of c.90%, in comparison with the national average of 7.6%, indicating that the innovative service model is far more accessible for users than traditional models.Real-world data also indicates that improvements in health and clinical outcomes for participants are superior and are achieved at lower cost to traditional models.This project will enable 300 participants to access Oviva Diabetes Support. An independent evaluation of the programme's impact on clinical outcomes following completion of the programme will be carried out by King's College London, which will be used to further analyse the potential for NHS cost-savings. In addition, the findings of the evaluation will be used to inform a larger clinical trial in future, which will seek to provide further evidence of clinical effectiveness."